On Tuesday, Ventyx Biosciences Inc (NASDAQ: VTYX) opened lower -4.02% from the last session, before settling in for the closing price of $2.49. Price fluctuations for VTYX have ranged from $1.87 to $40.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 28.45% at the time writing. With a float of $53.79 million, this company’s outstanding shares have now reached $59.24 million.
Let’s look at the performance matrix of the company that is accounted for 80 employees.
Ventyx Biosciences Inc (VTYX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ventyx Biosciences Inc is 23.70%, while institutional ownership is 74.31%. The most recent insider transaction that took place on Apr 02 ’24, was worth 23,299. In this transaction CEO AND PRESIDENT of this company sold 4,312 shares at a rate of $5.40, taking the stock ownership to the 1,578,250 shares. Before that another transaction happened on Apr 02 ’24, when Company’s CHIEF BUSINESS OFFICER sold 1,651 for $5.40, making the entire transaction worth $8,921. This insider now owns 284,999 shares in total.
Ventyx Biosciences Inc (VTYX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 3/31/2024, the company posted -0.91 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.71) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.45% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Check out the current performance indicators for Ventyx Biosciences Inc (VTYX). In the past quarter, the stock posted a quick ratio of 22.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.24, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -2.29 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (NASDAQ: VTYX) saw its 5-day average volume 0.91 million, a negative change from its year-to-date volume of 2.79 million. As of the previous 9 days, the stock’s Stochastic %D was 3.49%. Additionally, its Average True Range was 0.38.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 3.19%, which indicates a significant increase from 2.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 195.62% in the past 14 days, which was higher than the 160.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.10, while its 200-day Moving Average is $8.47. Nevertheless, the first resistance level for the watch stands at $2.50 in the near term. At $2.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.71. If the price goes on to break the first support level at $2.29, it is likely to go to the next support level at $2.20. Assuming the price breaks the second support level, the third support level stands at $2.08.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are currently 70,499K shares outstanding in the company with a market cap of 168.50 million. Presently, the company’s annual sales total 0 K according to its annual income of -192,960 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -38,570 K.
